Contagion®
Providing timely news to improve the diagnosis, treatment, and prevention of infectious diseases.
Read our coverage: contagionlive.com
- The latest CDC numbers on #measles show a significant increase of nearly 25%, in a week-to-week comparison. www.contagionlive.com/view/measles...
- In a phase 3 trial, the novel oral antiviral pritelivir demonstrated superior lesion healing and better tolerability than existing therapies in immunocompromised patients with refractory or resistant herpes simplex virus infections.
- In our new Antibiotics Deconstructed column, authors discuss the recently approved intravenous fosfomycin (Contepo), with an overview of the therapeutic including its mechanism of action, data, availability, and prospective costs. #IDsky #Medsky
- This is the fourth time the antimicrobial bill has been introduced in the Congress. Will the subscription-payment model legislation gain enough momentum for passage? #IDsky #Medsky www.contagionlive.com/view/pasteur...
- In the latest podcast, Dr. Andrea Prinzi talks about diagnostic stewardship and when it is grounded in collaboration, education, and thoughtful test use, it can improve patient care while helping clinicians navigate complex diagnostic tools. #IDsky
- A growing body of randomized trials and real-world analyses shows that starting metformin during acute SARS-CoV-2 infection is safe and significantly reduces the risk of developing #LongCovid #IDsky #Medsky www.contagionlive.com/view/metform...
- Paul Offit, MD, voices concerns over CDC’s surveillance capabilities, the federal agency’s lack of movement to address vaccine needs during outbreaks, and diminishing herd immunity, making the vulnerable at risk for contracting disease. @pauloffit.bsky.social #IDsky
- A review finds growing AMR among the main bacteria causing meningitis—especially in low- and middle-income countries—raising concerns about the continued effectiveness of standard treatments and the urgent need for stronger surveillance. #IDsky
- As the spending bill makes its way through Congress, Carl Schmid provides some insights on the latest wranglings on the #HIV bill and the domestic programs. #IDsky #Medsky
- MicuRx Pharmaceuticals has received FDA clearance to begin a phase 2a clinical trial of MRX-5, a novel oral antibacterial therapy for patients with Mycobacterium abscessus pulmonary disease. #IDsky #Medsky
